The five key “ingredients” for improving outcomes in cardiogenic shock complicating acute myocardial infarction

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 91, Iss. 3, 2018-02 ,pp. : 462-463

John Wiley & Sons Inc

Access to resources Recommend Favorite

Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 91, Iss. 3, 2018-02 ,pp. : 454-461

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angiopoietin‐2 in acute myocardial infarction complicated by cardiogenic shock—a biomarker substudy of the IABP‐SHOCK II‐Trial

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 11, 2015-11 ,pp. : 1152-1160

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use and outcome of radial versus femoral approach for primary PCI in patients with acute ST elevation myocardial infarction without cardiogenic shock: Results from the ALKK PCI registry

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. S1, 2015-10 ,pp. : S8-S14

John Wiley & Sons Inc

Access to resources Recommend Favorite

Short- and Long-Term Major Adverse Cardiac Events in Patients Undergoing Percutaneous Coronary Intervention with Stenting for Acute Myocardial Infarction Complicated by Cardiogenic Shock

By  

Cardiology, Vol. 121, Iss. 1, 2012-03 ,pp. : 47-55

Karger

Access to resources Recommend Favorite